ARHGAP33
Basic information
Region (hg38): 19:35774532-35788822
Previous symbols: [ "SNX26" ]
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 23.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
NM_001366178.1 | NP_001353107.1 | 21 | yes | - |
ENST00000007510.9 | ENSP00000007510.6 | 21 | yes | - |
NM_052948.4 | NP_443180.2 | 21 | - | - |
NM_001172630.2 | NP_001166101.1 | 17 | - | - |
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (178 variants)
- not_provided (8 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARHGAP33 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001366178.1. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 3 | 3 | 11 | ||
| missense | 177 | 5 | 182 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 0 | 184 | 8 | 3 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ARHGAP33 | protein_coding | protein_coding | ENST00000314737 | 21 | 14291 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125701 | 0 | 46 | 125747 | 0.000183 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.80 | 576 | 711 | 0.810 | 0.0000468 | 7016 |
| Missense in Polyphen | 171 | 193.49 | 0.88375 | 2036 | ||
| Synonymous | -0.276 | 310 | 304 | 1.02 | 0.0000198 | 2532 |
| Loss of Function | 5.03 | 14 | 53.9 | 0.260 | 0.00000310 | 529 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000589 | 0.000565 |
| Ashkenazi Jewish | 0.0000995 | 0.0000992 |
| East Asian | 0.000170 | 0.000163 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.000173 | 0.000167 |
| Middle Eastern | 0.000170 | 0.000163 |
| South Asian | 0.000131 | 0.000131 |
| Other | 0.000497 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in several stages of intracellular trafficking. Could play an important role in the regulation of glucose transport by insulin. May act as a downstream effector of RHOQ/TC10 in the regulation of insulin-stimulated glucose transport (By similarity). {ECO:0000250}.;
- Pathway
- Insulin Signaling;Signal Transduction;Rho GTPase cycle;Signaling by Rho GTPases
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.678
- rvis_EVS
- -1.46
- rvis_percentile_EVS
- 3.86
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- small GTPase mediated signal transduction;response to toxic substance;protein transport;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction;regulation of dendritic spine morphogenesis
- Cellular component
- cytoplasm;cytosol;plasma membrane;protein-containing complex;dendritic spine
- Molecular function
- GTPase activator activity;protein binding;protein kinase binding;phosphatidylinositol binding